192203-60-4
Chemical Structure
Carboxypeptidase G2 (CPG2) Inhibitor
Synonym(s): CPG2 Inhibitor
- CAS No.: 192203-60-4
- Formula:C13H15NO6S
- Molecular Weight:313.33
IUPAC Name: (((4-methoxyphenyl)thio)carbonyl)-L-glutamic acid
InChIKey: OBCGYIKABKFIQB-JTQLQIEISA-N
SMILES: O=C(SC(C=C1)=CC=C1OC)N[C@@H](CCC(O)=O)C(O)=O
Biological Activity: Carboxypeptidase G2 (CPG2) Inhibitor is a novel CPG2 inhibitor with an Ki of 0.3 μM. Carboxypeptidase G2 (CPG2) Inhibitor effectively neutralizes the CPG2 activity in non-tumor sites, allowing for earlier administration of the drug and forming a complementary strategy with antibody clearance strategies. Carboxypeptidase G2 (CPG2) Inhibitor can be used for the study of antibody-directed enzyme prodrug therapy (ADEPT)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Carboxypeptidase G2 (CPG2) Inhibitor | 98.02% | Carboxypeptidase G2 (CPG2) Inhibitor is a novel CPG2 inhibitor with an Ki of 0.3 μM. Carboxypeptidase G2 (CPG2) Inhibitor effectively neutralizes the CPG2 activity in non-tumor sites, allowing for earlier administration of the drug and forming a complementary strategy with antibody clearance strategies. Carboxypeptidase G2 (CPG2) Inhibitor can be used for the study of antibody-directed enzyme prodrug therapy (ADEPT). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
